TMDX / Transmedics Group, Inc. (TMDX) Q1 2023 Earnings Call Transcript

Today, we put the focus on TransMedics Group, Inc., a healthcare company focused on transforming the organ transport and transplant industry. The comp more_horizontal

TransMedics is a medical tech company focused on organ transplants in the US. TMDX looks set to be a key enabler in raising the transplant volumes car more_horizontal

Hospitals and transplant centers increasingly rely on TransMedics Group to retrieve donated hearts, lungs, and livers, and deliver them long distances more_horizontal

TransMedics' (TMDX) acquisition of Summit Aviation is likely to help establish TransMedics Aviation, the first integrated national provider of air log more_horizontal

The company's Organ Care System is used to improve transplant outcomes for heart, liver, and lung transplants. It improved revenue and trimmed its los more_horizontal

TransMedics Group, Inc. (NASDAQ:TMDX ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Brian Johnston - Gilmartin Grou more_horizontal

TransMedics (TMDX) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of more_horizontal

TransMedics Group reported impressive first-quarter earnings on May 1, but the stock slipped anyway. TransMedics Group markets an organ-care system th more_horizontal